**Medicus Pharma Ltd. Announces Change in Certifying Accountants Amidst Financial Concerns** June 5, 2025 - Medicus Pharma Ltd. has announced the dismissal of EisnerAmper LLP as its independent registered public accounting firm, following a recommendation by the company's audit committee and approval by the board of directors. The decision comes after EisnerAmper raised concerns about the company's ability to continue as a going concern due to negative cash flows and operating losses. EisnerAmper's report for the fiscal year ending December 31, 2024, highlighted substantial doubt about Medicus Pharma's financial stability, although it did not issue an adverse opinion or disclaimer. Despite these concerns, there were no disagreements between the company and EisnerAmper on accounting principles or practices. KPMG LLP has been appointed as the new independent registered public accounting firm, with EisnerAmper authorized to fully cooperate with the transition. This change follows disclosures of material weaknesses in the company's internal financial reporting controls, as noted in its annual report. Medicus Pharma is addressing these issues as part of management's ongoing efforts to stabilize the company's financial health.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。